FDA Greenlights Pioneering Test for Detecting Increased Risk of Opioid Use Disorder

January 07, 2024

Read More  

FDA Grants Approval to First Treatment for Uncommon Non-Malignant Tumors

December 05, 2023

Read More  

FDA approves first targeted therapy for myelodysplastic syndromes

October 22, 2023

Read More  

FDA Approves Omisirge for Patients with Blood Cancers to Quicken the Recovery of Neutrophils Following Stem Cell Transplantation

April 28, 2023

Read More  

List of the Authorized At-Home OTC COVID-19 Diagnostic Tests

July 5, 2022

Read More  

Products marketed for Removing Moles or other Skin Lesions can Cause Injuries

June 9, 2022

Read More  

FDA Approves First Treatment for Eosinophilic Esophagitis

May 20, 2022

Read More  

FDA approved two anti-COVID-19 drugs and authorized others for emergency use

May 19. 2022

Read More  

FDA Approves Oral Form of Edaravone for the treatment of ALS (Lou Gehrig's disease)

May 12, 2022

Read More  

FDA Approves First COVID-19 Treatment for Young Children: Remdesevir

April 25, 2022

Read More